Insights from Londons' 2024 Cannabis Europa Conference

Day 1 of Cannabis Europa 2024 in London provided a deep dive into the regulatory and investment challenges facing the European cannabis industry. The conference began with a series of panels that examined the current state of cannabis regulation and its impact on the market. One panel, titled ‘A Gear Shift for Cannabis in Europe,’ humorously noted that the past year felt more like a "handbrake" than a gear shift due to regulatory hurdles.

Sam Volkering from Southbank Investment Research highlighted the critical issue of profitability and cash flow for cannabis companies, noting that without these, securing investment is nearly impossible. Sean Stiefel, CEO of Navy Capital, emphasized that the lack of regulatory clarity is the biggest barrier to investment. He stated that even promising businesses struggle to attract investors due to uncertainty about how long they will last under current regulations.

The conference also touched on the issue of consolidation in the industry. Stiefel remarked that the cannabis market, like the alcohol industry, is likely to end up dominated by a few large conglomerates, with room for regional and craft businesses. Despite the current challenges, he expressed optimism about the future, predicting that the US cannabis market could eventually reach a $100 billion valuation.

Nick Davis from Memery Crystal discussed the legal complexities in the UK, particularly the proceeds-of-crime regulations, which add another layer of difficulty for cannabis companies seeking investment. He pointed out that other jurisdictions, like Jersey, have clarified their laws to better accommodate the cannabis industry, suggesting that the UK could benefit from similar reforms.

The first day of Cannabis Europa highlighted the need for strategic adaptation and resilience in the cannabis sector. Industry leaders called for clearer regulations and emphasized the importance of profitability and sustainable business models. Despite the hurdles, there was a shared sense of optimism about the potential for significant growth and development in the cannabis market.

Day 2 of Cannabis Europa 2024 in London was a continuation of the previous day’s momentum, characterized by insightful discussions and significant industry developments. The day began by acknowledging the winners of the Business of Cannabis Awards, which celebrated notable achievements in the cannabis industry. Among the recognized were Curaleaf, Hannah Deacon, Cannavigia, Medicann, and Cannareporter, highlighting their contributions to advancing cannabis acceptance and regulatory progress.

The discussions on Day 2 centered around the exponential growth and global momentum of the cannabis industry, with a focus on how Europe can harness this energy to drive forward cannabis reforms. A significant portion of the day was dedicated to examining the progress and implications of Germany’s CanG bill, a landmark legislation aimed at legalizing cannabis. Speakers expressed concerns about potential delays and amendments to the bill, which is seen as a crucial step for the European market. The discussions emphasized the interconnectedness of global cannabis policies, noting how changes in legislation in one region can influence market dynamics worldwide. The potential impact of Germany’s legislation on stock prices and the broader market was also highlighted, with speakers stressing the importance of regulatory clarity to attract investment and support industry growth.

Innovation and strategic growth within the industry were key themes throughout the day. Panels explored new business models and partnerships, such as Somaí Pharmaceuticals' acquisition of RPK Biopharma, which positions the company as a leader in the medicinal cannabis sector. These discussions underscored the importance of adapting to the evolving market landscape and leveraging new opportunities for growth. The day concluded with a sense of optimism and determination, as speakers and attendees alike emphasized the need for continued advocacy, innovation, and collaboration to overcome regulatory hurdles and realize the full potential of the cannabis industry.

Overall, Cannabis Europa 2024 underscored the resilience and optimism within the cannabis industry. The event provided a comprehensive overview of the current state and future prospects of cannabis, stressing the importance of advocacy, collaboration, and innovation in overcoming challenges and realizing the full potential of this burgeoning sector.

By Daniel Cuirea

Source: